Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 2, 2012, Pages 402-405

  Aksu, Buket ^a   De Beer, Thomas ^b   Folestad, Staffan ^c   Ketolainen, Jarkko ^e   Lindén, Hans ^f   Lopes, Joao Almeida ^g   De Matas, Marcel ^d   Oostra, Wim ^h   Rantanen, Jukka ⁱ   Weimer, Marco ^j  

^a Santa Farma Pharmaceuticals   (Turkey)

^b GHENT UNIVERSITY   (Belgium)

^c ASTRAZENECA R AND D   (Sweden)

^d ASTRAZENECA   (United Kingdom)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f European Federation for Pharmaceutical Sciences (EUFEPS)   (Sweden)

^g UNIVERSITY OF PORTO   (Portugal)

^h PSCS   (Netherlands)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j Process Development Biotechnology   (Germany)

more..

Author keywords

Biopharmaceuticals; Continuous processing; Personalized healthcare; Process Analytical Technology (PAT); Product design; Quality by Design (QbD)

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; FUNDING; HEALTH CARE; HUMAN; LIFE CYCLE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROCESS ANALYTICAL TECHNOLOGY; QUALITY BY DESIGN; QUALITY CONTROL; QUALITY CONTROL PROCEDURES; REVIEW;

EID: 84864414536     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.06.009     Document Type: Note

References (20)

1. Dhenge, R.M., Washino, K., Cartwright, J.J., Hounslow, M.J. and Salman, A.D., 2012. Twin screw granulation using conveying screws: effects of viscosity of granulation liquids and flow of powders. Powder Technol.
2. S. Frokjaer, and D.E. Otzen Protein drug stability: a formulating challenge Nature 4 2005 298 306
3. Y. Gao, M. Ierapetritou, and F. Muzzio Periodic section modeling of convective continuous powder mixing AlChe J. 58 1 2012 69 78
4. J. Glassey, K.V. Gernaey, C. Clemens, T.W. Schulz, R. Oliveira, G. Striedner, and C.-F. Mandenius Process analytical technology (PAT) for biopharmaceuticals Biotechnol. J. 6 2011 369 377
5. J. Guo, S. Pandey, J. Doyle, B. Bian, Y. Lis, and D. Raisch A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy - report of the ISPOR risk-benefit management working group Value Health 5 13 2010 657 666
6. M. Holweg The genealogy of lean production J. Ops. Manuf. 25 2 2007 420 437
7. ICH Q9 Quality Risk Management. ICH Guidance for Industry, November 2005.
8. ICH Q10 Quality Systems. ICH Guidance for Industry, June 2008. < http://www.ich.org >.
9. ICH Q8R(2) Pharmaceutical Development. ICH Guidance for Industry, August 2009.
10. Kansakoski, M., Kurkinen, M., von Weymarn, N., Niemela, P., 2006. Process analytical technology (PAT) needs and applications in the bioprocess industry (Review), VTT. < http://www.vtt.fi/inf/pdf/workingpapers/2006/W60.pdf >.
11. M. Kussel The problems with today's pharmaceutical business - an outsider's view Nature Biotech. 29 2011 27 33
12. M. Närhi, and K. Nordström Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective Eur. J. Pharm. Sci. 59 3 2005 397 405
13. Editorial. 2012. What happened to personalized medicine? Nature Biotechnol. 30(1), 1.
14. Pricewaterhouse Coopers., 2009. Pharma 2020: The Vision - Which path will you take?
15. Pharmaceutical cGMPs for the 21st century - A risk based approach - Final Report, US FDA 2004.
16. K. Plumb Continuous processing in the Pharmaceutical Industry - changing the mindset Chem. Eng. Res. Des. 83 6 2005 730 735
17. E.K. Read, J.T. Park, R.B. Shah, B.S. Riley, K.A. Brorson, and A.S. Rathore Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications Biotechnol. Bioeng. 105 2 2010 276 284
18. S.D. Schaber, D.I. Gerogiorgis, R. Ramachandran, J.M.B. Evans, D.I. Barton, and B.L. Trout Economic analysis of integrated continuous and batch pharmaceutical manufacturing Ind. Eng. Chem. Res. 50 2011 10083 10092
19. L.J. van't Veer, and R. Bernards Enabling personalized cancer medicine through analysis of gene-expression patterns Nature 452 2008 564 570
20. K. Wening, and J. Breitkreutz Novel delivery device for monolithical solid oral dosage forms for personalized medicine Int. J. Pharm. 395 2010 174 181